Development of hyperplasias, preneoplasias, and mammary tumors in MMTV- c-erbB-2 and MMTV-TGFα transgenic rats

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 303-314

  Davies, Barry R ^a   Platt Higgins, Angela M ^b   Schmidt, Gunter ^c   Rudland, Philip S ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c Brax Genomics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST HYPERPLASIA; BREAST TUMOR; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE CONSTRUCT; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; LONG TERMINAL REPEAT; MALE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE C ERB; ONCOGENE NEU; PHENOTYPE; PRIORITY JOURNAL; RAT; TRANSGENIC ANIMAL;

EID: 0033031879     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65124-3     Document Type: Article

References (55)

1. Amundadottir LT, Merlino G, Dickson RB: Transgenic mouse models of breast cancer. Breast Cancer Res Treat 1996, 39:119-135
2. Cardiff RD: The biology of mammary transgenes: five rules. J Mammary Gland. Biol Neoplasia 1996, 1:61-74
3. Edwards PAW, Abram CA, Bradbury JM: Genetic manipulation of mammary epithelium by transplantation. J Mammary Gland Biol Neoplasia 1996, 1:75-90
4. Yamada S, Ikeda H, Yamazaki, H, Shikishima H, Kikuchi K, Wakisaka A, Kasai N, Shimotohno K, Yoshiki T: Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res 1995, 55:2524-2527
5. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zweiten MJ: Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990, 62:244-278
6. Young S, Hallowes PC: Tumors of the mammary gland. Pathology of Tumors in Laboratory Animals, vol 1. Edited by Turosov VS. Lyon, France, IARC Science Publishers, 1973, pp 31-74
7. Marquardt H, Klunkapillar MW, Hood LH, Twardzik DR, DeLarco JE, Stephenson JR, Todovo GJ: Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc Natl Acad Sci USA 1983, 80:4684-4688
8. Massague J: Epidermal-like transforming growth factor 2. J Biol Chem 1983, 258:13614-13620
9. Smith JA, Barraclough R, Fernig DG, Rudland PS: Identification of α transforming growth factor as a possible local trophic agent for the mammary gland. J Cell Physiol 1989, 141:363-370
10. Normanno N, Ciardiello F, Brandt R, Salomon DS: EGF-related peptides in the pathogenesis of human breast cancer. Breast Cancer Res Treat 1994, 29:11-27
11. Parham DM, Jankowski J: TGFα in epithelial proliferative diseases of the breast. J Clin Pathol 1992, 45:513-516
12. Lundy J, Schuss A, Stanick D, McCormack ES, Kramer S, Sorvillo JM: Expression of neu protein, EGF receptor and TGFα in breast cancer: correlation with clinicopathological parameters. Am J Pathol 1991, 138:1527-1534
13. McAndrew J, Rudland PS, Platt-Higgins AM, Smith JA: Immunolocalisation of a transforming growth factor in the developing rat mammary gland in vivo, rat mammary cells in vitro and in human breast diseases. Histochem J 1994, 26:355-366
14. Umekita Y, Enokizono N, Sagara Y, Kuriwaki K, Takasaki T, Yoshida A, Yoshida S: Immunohistochemical studies on oncogene products (EGF, TGFα) in human breast cancer: their relationship to ER status, histology, grade, mitotic index and nodal status. Virchows Arch A Pathol Anat 1992, 420:345-351
15. Coussens L, Yang-Feng TL, Liao Y-C, Chen E, Gray A, McGrath J, Seenburg PH, Levinson A, Ullrich A: Tyrosine kinase receptor with extensive homology to the EGF receptor shares chromosomal location with the neu oncogene. Science 1985, 230:1132-1139
16. Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K: Similarity of protein encoded by the human c-erb-B2 gene to epidermal growth factor receptor. Nature 1986, 319:230-234
17. Shin C, Padhy LC, Murray M, Weinberg RA: Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 1981, 290:261-264
18. Bargmann CI, Hung M-C, Weinberg RA: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 1986, 45:649-657
19. Press MF, Cordon-Cardo C, Slamon DJ: Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 1990, 5:953-962
20. Slamon DJ, Clark GM, Wang SG, Levin, WJ, Ullrich A, McGuire WC: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182
21. Slamon DJ, Godolphin W, Jones LA: Studies of HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989, 244: 707-712
22. Winstanley JHR, Cooke T, Murray GD, Platt-Higgins A, George WD, Holt S, Myskov M, Spedding A, Barraclough BR, Rudland PS: The long term prognostic significance of c-erb-B2 in primary breast cancer. Br J Cancer 1991, 63:447-450
23. van de Vijver MJ, Peterse JL, Mooi WJ, Wiseman P, Limons J, Dalesio O, Nusse R: neu-protein overexpression in breast cancer. N Engl J Med 1988, 319:1239-1245
24. Gusterson BA, Machin LG, Gullick, WJ, Gibbs NM, Powles TJ, Elliot C, Ashley S, Monaghan P, Harrison S: c-erb-B2 expression in benign and malignant breast disease. Br J Cancer 1988, 58:453-458
25. Lui E, Thor A, He M, Barcos M, Ljung BM, Benz C: The HER-2 (c-erb-B2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene 1992, 7:1027-1032
26. Gullick WJ: The role of the EGF receptor and the c-erb-B2 protein in breast cancer. Int J Cancer 1990, 55:55-61
27. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988, 54:105-115
28. Guy CT, Webster MA, Scholler M, Parsons T, Cardiff RD, Muller WJ: Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 1992, 89:10578-10582
29. Luccini F, Sacco MG, Hu N, Villa A, Brown J, Cesano L, Mangiarini L, Rindi G, Kindl S, Sessa F, Vezzoni P, Clerici L: Early and multifocal tumors in breast, salivary, Harderian and epididymal tissues developed in MMTV-neu transgenic mice. Cancer Lett 1992, 64:203-209
30. Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P: Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV c-neu proto-oncogene. Cell 1989, 57:931-936
31. Suda Y, Aizawa S, Furuta Y, Yagi T, Ikawa Y, Saitoh K, Yamada Y, Toyoshima K, Yamamoto T: Induction of a variety of tumors by c-erb-B2 and clonal nature of lymphomas even with the mutated gene (Val 659 to Glu 659). EMBO J 1990, 9:181-190
32. Guy CT, Webster MA, Schaller M, Parson TJ, Cardiff RD, Muller WJ: Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 1992, 89:10578-10582
33. Siegel PM, Dankort DL, Hardy WR, Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 1994, 14:7068-7077
34. Lathe R, Vilotte JL, Clark AJ: Plasmid and bacteriophage vectors for excision of intact inserts. Gene 1987, 57:193-201
35. Hogan B, Constantini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1986
36. Armstrong DT, Opavsky MA: Superovulation of immature rats by continuous infusion of FSH. Biol Reprod 1988, 39:511-518
37. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD: Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 1985, 82:4438-4442
38. Warren J, Blakemore S: Theriogenology 1993, 9:337
39. Sambrook J, Fitsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
40. Soule HD, Vazquez A, Long A, Albert S, Brennan MA: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973, 51:1409-1413
41. Banergee MR, Wood BG, Lin FK, Crump LR: Tissue Culture Association Manual, vol 2. Edited by Sanford KK. Gaithersburg, MD, TCA, 1976, pp 457-462
42. Royal College of Pathologists Working Group: Pathology reporting in breast cancer screening. J Clin Pathol 1991, 44:710-725
43. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29: 577-580
44. Warburton MJ, Mitchell D, Ormerod EJ, Rudland PS: Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating and involuting rat mammary gland. J Histochem Cytochem 1982, 30:667-676
45. Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 1990, 61:1147-1155
46. Halter SA, Dempsey P, Matsui Y, Stokes MK, Graves-Deal R, Hogan BLM, Coffey RJ: Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor α: characterization of mammary gland and skin proliferations. Am J Pathol 1992, 140:1131-1146
47. Smith GH, Sharp R, Kardan EJ, Jhappan C, Merlino GT: Transforming growth factor a promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 1994, 147:1081-1096
48. Sandgen EP, Schroder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC: Inhibition of mammary gland involution is associated with transforming growth factor a but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 1995, 55:3915-3927
49. Jhappan C, Stable C, Harkins RN, Fausto N, Smith GH, Merlino GT: TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146
50. Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P, Leder P: The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 1990, 9:907-913
51. Stamp G, Frentl V, Poulsden R, Jamieson S, Smith R, Peters G, Dickson C: Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors. Cell Growth Differ 1992, 3:929-939
52. Kitzberg DI, Leder P: Keratinocyte growth factor induces mammary and prostatio hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 1996, 13:2507-2515
53. Foulds L: Mammary tumors in hybrid mice: the presence and transmission of the mammary tumor agent. Br J Cancer 1949, 3:230-239
54. Haraguchi S, Good RA, Engelman RW, Day, NK: Human prolactin regulates transfected MMTV LTR-directed gene expression in a human breast carcinoma cell line through synergistic interaction with steroid hormones. Int J Cancer 1992, 52:928-933
55. Bradbury JM, Arno J, Edwards PAW: Induction of epithelial abnormalities that resemble human breast lesions by the expression of the neu/erb-B2 oncogene in reconstituted mouse mammary gland. Oncogene 1993, 8:1551-1558